Diabetic Therapy
METSIFERâ„¢ VG2
Glimepiride 2mg + Metformin 500mg + Voglibose 0.2mg
Dosage Form
Tablets (bi-layered)
Packing
10x15 Blister
MRP
₹2250
Prescribed By
Diabetologist, Endocrinologist, General Physician, Internal Medicine, Family Medicine
Quick Facts
Form
Bi-Layered Tablets
Pack
10×15 Blister
MRP
₹2250
Prescribed By
Diabetologist, Endocrinologist, General Physician
Key Benefits
01
Higher Glimepiride dose for patients needing stronger control.
02
Voglibose targets post-meal glucose rises.
03
Three mechanisms working together for thorough glucose management.
04
Convenient single tablet.
Mechanism of Action
Glimepiride 2mg provides stronger insulin stimulation. Metformin controls basal glucose. Voglibose reduces post-meal glucose absorption. Triple action covers fasting, post-meal, and overall insulin resistance.
Indications
Type 2 diabetes requiring stronger combination therapy with post-meal control.
Dosage & Administration
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
Why METSIFERâ„¢ VG2?
METSIFER VG2 is a robust triple combination for patients with poorly controlled Type 2 diabetes — providing comprehensive fasting and post-meal glucose control in one convenient tablet.
